Morgan Stanley (NYSE:MS) adjusted its outlook on Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX) shares, raising the price target from the previous $450.00 to $459.00, while maintaining an ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback